Navigation Links
The United States Patent and Trademark Office Grants TransUnion Patent for Healthcare Financing Method
Date:3/31/2008

Helps defray the cost of treating the uninsured through automated

eligibility by matching more patients to entitlement and assistance

programs

CHICAGO, March 31 /PRNewswire/ -- TransUnion announced today that its healthcare financing method was granted United States Patent No. 7,333,937 on Feb. 19, 2008 for the Healthcare Revenue Cycle Platform (HRCP). HRCP is an ASP-based technology platform that determines, in real time, patient eligibility for financial assistance at point of registration.

This business method patent utilizes healthcare financial aid information associated with federal, state, and local assistance plans to help appropriately determine both patient eligibility for assistance and patient responsibility for costs related to medical treatment.

"This patent solidifies TransUnion as a market leader in marrying information and technology to address a critical business issue our healthcare customers are facing in this financially challenging market -- escalating bad debt," said Rod Bazzani, executive vice president of healthcare for TransUnion. "Our proprietary business method allows hospitals to utilize an automated and sophisticated rules-based decision engine to ensure their patients are best served while ensuring all necessary guidelines to maximize financial aid are met."

With this newly patented technology, hospitals can utilize a web-based system to electronically input patient data at the time of service that is cross-referenced with credit-sourced information to determine patient eligibility for all appropriate benefit sources, including hospital-specific charity programs. The software queries federal and state programs including Medicaid, Victims of Crime, Emtala Section 1011 Reimbursement, Ryan White Program as well as grant, foundation, and charity care programs, all of which offer healthcare financial assistance for qualifying applicants.

The patented techno
'/>"/>

SOURCE TransUnion
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Statement in Response to SEIU United Healthcare Workers - Wests (UHW-W) Thursday Media Event
2. Study: Dramatic rise in hepatitis C-related deaths in the United States
3. AUDIO from Medialink and UnitedHealthcare: Medicare Open Enrollment Ends March 31
4. New report highlights variations in approaches to thoracic surgery in the United Kingdom and Ireland
5. Providence Service Corporation and UnitedHealth Group Affiliate, OptumHealth Behavioral Solutions, Enter Into Strategic Relationship Agreement
6. United Mitochondrial Disease Foundation Statement on Vaccines, Autism and Mitochondrial Disease
7. Religious Leaders Join The Balm In Gilead to Support The Big Coffee Project, to Help Fight HIV/AIDS in the United States and in Africa
8. United States and Mexico Renew Agreement on Cooperation in Health
9. Bi-Partisan Members of United States Senate Formally Raise Concerns About Proposed Cuts to Medicares Home Oxygen Benefit
10. Hospital Groups United in Opposition to Charity Care Cuts
11. Justice Department Requires Divestiture in UnitedHealth Groups Acquisition of Sierra Health Services

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2009)...of Navarra Hospital has launched a series of clini...mmunotherapy treatment. This approach involves the...m healthy and tumour cells from the patient him or... of the most aggressive and frequent malignant tum...ting patients combined with the standard, first-li...
(Date:11/30/2009)... Author of "My Two-Year Old Eats Octo...n who love to eat everything. , ...picky eater in your house? Do you find yourself a...w short online videos – one focusing on pack...rd on answers for real-life parents’ questio...
(Date:11/30/2009)...at worsens over time, so do knees, internal injuri...ealthDay News) -- If you,re a middle-age weekend w...ckey rink, take note: A new study suggests that hi...nternal knee damage that could lead to osteoarthri...ed in middle-age people who showed no symptoms and...
(Date:11/30/2009)..., SHENZHEN, China, Nov. 30 /PRNewswire-FirstCall/...medical.com/ ) operating subsidiary Mellow Hope fi...anufacturer of intravenous medication in India. Th...es for Hard to Treat Diseases in the following qua...ian company secures the supply of raw pharmaceutic...
(Date:11/30/2009)... Red Cross offers online giving catalog to help fa... ,, WASHINGTON, Nov. 30 /PRNewswire-USNewswir... are entering this holiday season willing to suppo... to dig deep into their own wallets to support cha...bout donating to charity instead of buying them a ...
Breaking Medicine News(10 mins):Health News:Clinical trials launched for treating most aggressive brain tumor with personalized cell vaccines 2Health News:Clinical trials launched for treating most aggressive brain tumor with personalized cell vaccines 3Health News:Clinical trials launched for treating most aggressive brain tumor with personalized cell vaccines 4Health News:Clinical trials launched for treating most aggressive brain tumor with personalized cell vaccines 5Health News:Clinical trials launched for treating most aggressive brain tumor with personalized cell vaccines 6Health News:New Videos Help Parents of Picky Eaters 2Health News:New Videos Help Parents of Picky Eaters 3Health News:Lots of Exercise in Midlife May Lead to Osteoarthritis 2Health News:Lots of Exercise in Midlife May Lead to Osteoarthritis 3Health News:Hard to Treat Diseases (HTDS) Closes 1 Million Dollar Contract Indian Pharmaceutical 2Health News:Hard to Treat Diseases (HTDS) Closes 1 Million Dollar Contract Indian Pharmaceutical 3Health News:American Red Cross Survey Finds 62 Percent of Americans Plan to Donate More Than $25 to Charity This Holiday Season in Spite of Economic Downturn 2Health News:American Red Cross Survey Finds 62 Percent of Americans Plan to Donate More Than $25 to Charity This Holiday Season in Spite of Economic Downturn 3
...17-year old Irish girl who made headlines recently... by asserting her right to abort has got the nod ...the Court demanding that she be allowed to go to B...the foetus she is carrying suffers from anencephal...
...new vaccine aimed at preventing cervical cancer is...s of the human papillomavirus (HPV) responsible f...ionwide study of the vaccine will be published in ...ine marketed by Merck under the name Gardasil coul...
...combination of molecular-targeted therapy and horm...earch for those seeking an effective treatment fo... International Journal of Gynecological Cancer. ...tumors, says review author Dr. Siqing Fu, an assis...
...dia is home to over 76.6 million people over the a...e health ministry, the country has 76,622,321 per...cent of the elderly population, Uttar Pradesh tops... have 5.5 million senior citizens each. De...
... line with Ranbaxy Laboratories aggressive interna... Africa's Competition Commission has solidified th...mited ("Be-Tabs") by Ranbaxy Laboratories. (RNBV).... Ranbaxy Laboratories Limited, headquartered...
...alth authorities in the US are worried about yet a...quito-spread infection. Rudy Bueno, the Chi...id that the situation may worsen if people don't f...ellants or going out at night in short-sleeve shir...
Other Medicine News:Health News:Pregnant Irish Teenager Wins the Right to Abort 2Health News:Study Shows Continued Success for New HPV Vaccine Against Virus 2Health News:Ranbaxy Labs Extends Roots in South Africa 2Health News:Ranbaxy Labs Extends Roots in South Africa 3Health News:Health Authorities Fear West Nile Season Again in US 2
(Date:11/30/2009)...ewswire/ -- Reportlinker.com announces that a new ...ue: ,, Outsourcing Opportunities in the Medica...nker.com/p0165747/Outsourcing-Opportunities-in-the..., Medical devices form one of the largest indust...f $250 billion in 2009 and a growth rate of 6%-8%....
(Date:11/30/2009)...Newswire/ -- StemCyte, Inc. concluded an exclusive...emia Sinica, the National Laboratory of Taiwan, fo...perty (IP) related to the treatment of Chronic Str...ered by a team led by Professor John Lin, MD, PhD ...currently the exclusive collaborator with StemCyte...
(Date:11/30/2009)...0 Cytokine PharmaSciences, Inc. to... CPSI-2364, its orally active, small-molecule inhi...-inflammatory cytokines. Results of the safety an...lunteers confirm the safety of this compound in in...bjects completed the study, including those receiv...
Breaking Medicine Technology:Reportlinker Adds Outsourcing Opportunities in the Medical Device (2009 - 2014) 2Reportlinker Adds Outsourcing Opportunities in the Medical Device (2009 - 2014) 3Reportlinker Adds Outsourcing Opportunities in the Medical Device (2009 - 2014) 4Reportlinker Adds Outsourcing Opportunities in the Medical Device (2009 - 2014) 5Reportlinker Adds Outsourcing Opportunities in the Medical Device (2009 - 2014) 6Reportlinker Adds Outsourcing Opportunities in the Medical Device (2009 - 2014) 7Reportlinker Adds Outsourcing Opportunities in the Medical Device (2009 - 2014) 8Reportlinker Adds Outsourcing Opportunities in the Medical Device (2009 - 2014) 9StemCyte Licenses Promising IP for Stem Cell Therapy to Treat Stroke 2StemCyte Licenses Promising IP for Stem Cell Therapy to Treat Stroke 3Cytokine PharmaSciences Completes Phase I Study of Oral Anti-Inflammatory Agent, CPSI-2364 2Surviving Healthcare Reform 3A How Biopharma Companies Can Come Out on Top 60842 1Surviving Healthcare Reform 3A How Biopharma Companies Can Come Out on Top 60842 2Mineral BioSciences to Attend SupplySide West in Las Vegas 60837 1Mineral BioSciences to Attend SupplySide West in Las Vegas 60837 2Poor Restroom Cleaning Causes Cruise Ship Sickness 60833 1Poor Restroom Cleaning Causes Cruise Ship Sickness 60833 2
...of its Kind to Achieve Enrollment Milestone, MENL...,in the development of devices for the percutaneou...mpletion of randomized enrollment in the,Endovascu...ch is evaluating,the MitraClip(R) system as a non-... mitral regurgitation (MR). MR is the most common ...
...ry, Sept. 30 ,Forest Laboratories, Inc. (NYSE: FR...nary top-line results from a phase II clinical tri...tipsychotic, in patients with,acute mania associat...nt,the Young Mania Rating Scale (YMRS), the data s...ted with cariprazine experienced significant,sympt...
Other Medicine Technology:Evalve Announces Enrollment Completion of the EVEREST Randomized Study 2Evalve Announces Enrollment Completion of the EVEREST Randomized Study 3Forest Laboratories, Inc. and Gedeon Richter Plc Announce Positive Phase II Results with the Investigational Antipsychotic Cariprazine in Patients with Acute Mania Associated with Bipolar I Disorder 2Forest Laboratories, Inc. and Gedeon Richter Plc Announce Positive Phase II Results with the Investigational Antipsychotic Cariprazine in Patients with Acute Mania Associated with Bipolar I Disorder 3Forest Laboratories, Inc. and Gedeon Richter Plc Announce Positive Phase II Results with the Investigational Antipsychotic Cariprazine in Patients with Acute Mania Associated with Bipolar I Disorder 4Forest Laboratories, Inc. and Gedeon Richter Plc Announce Positive Phase II Results with the Investigational Antipsychotic Cariprazine in Patients with Acute Mania Associated with Bipolar I Disorder 5
Core Malaria Pv-Pf
NOW® Malaria Test (P. Falciparum)
Ultraview 1700 Central Monitor
...Central Station provide an example of the Witt int...or electrophysiology lab to healthcare professiona...viding both physiomonitoring parameters and electr...on its own network. Witts Central Station can moni...
Medicine Products: